| Product Code: ETC7646958 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to rely on imports of budesonide inhalers, with top exporting countries being Switzerland, UK, Belgium, USA, and Germany. The low Herfindahl-Hirschman Index (HHI) indicates a competitive market landscape. However, the compound annual growth rate (CAGR) for 2020-2024 was negative at -2.14%, with a slight decline in growth rate from 2023 to 2024 at -0.41%. This data suggests a stable but challenging market environment for budesonide inhaler imports in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Budesonide Inhaler Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Budesonide Inhaler Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Budesonide Inhaler Market - Industry Life Cycle |
3.4 Israel Budesonide Inhaler Market - Porter's Five Forces |
3.5 Israel Budesonide Inhaler Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Budesonide Inhaler Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 Israel Budesonide Inhaler Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.8 Israel Budesonide Inhaler Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Budesonide Inhaler Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Budesonide Inhaler Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory disorders in Israel |
4.2.2 Growing awareness about the benefits of using budesonide inhalers for asthma and COPD management |
4.2.3 Technological advancements in inhaler devices leading to improved drug delivery |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Competition from alternative treatment options such as oral medications |
4.3.3 Potential side effects associated with long-term use of budesonide inhalers |
5 Israel Budesonide Inhaler Market Trends |
6 Israel Budesonide Inhaler Market, By Types |
6.1 Israel Budesonide Inhaler Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Budesonide Inhaler Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Budesonide Inhaler Market Revenues & Volume, By Nebulizer, 2021- 2031F |
6.1.4 Israel Budesonide Inhaler Market Revenues & Volume, By Inhalants, 2021- 2031F |
6.2 Israel Budesonide Inhaler Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 Israel Budesonide Inhaler Market Revenues & Volume, By Dry Powder, 2021- 2031F |
6.2.3 Israel Budesonide Inhaler Market Revenues & Volume, By Spray, 2021- 2031F |
6.2.4 Israel Budesonide Inhaler Market Revenues & Volume, By Suspension, 2021- 2031F |
6.2.5 Israel Budesonide Inhaler Market Revenues & Volume, By Aerosols, 2021- 2031F |
6.3 Israel Budesonide Inhaler Market, By Strength |
6.3.1 Overview and Analysis |
6.3.2 Israel Budesonide Inhaler Market Revenues & Volume, By 0.25mg, 2021- 2031F |
6.3.3 Israel Budesonide Inhaler Market Revenues & Volume, By 0.5mg, 2021- 2031F |
6.3.4 Israel Budesonide Inhaler Market Revenues & Volume, By 1.0mg, 2021- 2031F |
6.4 Israel Budesonide Inhaler Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Budesonide Inhaler Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Israel Budesonide Inhaler Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5 Israel Budesonide Inhaler Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Budesonide Inhaler Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Budesonide Inhaler Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Israel Budesonide Inhaler Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Israel Budesonide Inhaler Market Import-Export Trade Statistics |
7.1 Israel Budesonide Inhaler Market Export to Major Countries |
7.2 Israel Budesonide Inhaler Market Imports from Major Countries |
8 Israel Budesonide Inhaler Market Key Performance Indicators |
8.1 Patient adherence rate to budesonide inhaler therapy |
8.2 Number of healthcare providers prescribing budesonide inhalers |
8.3 Rate of hospitalizations for respiratory exacerbations among patients using budesonide inhalers |
9 Israel Budesonide Inhaler Market - Opportunity Assessment |
9.1 Israel Budesonide Inhaler Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Budesonide Inhaler Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.3 Israel Budesonide Inhaler Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.4 Israel Budesonide Inhaler Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Budesonide Inhaler Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Budesonide Inhaler Market - Competitive Landscape |
10.1 Israel Budesonide Inhaler Market Revenue Share, By Companies, 2024 |
10.2 Israel Budesonide Inhaler Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |